Allergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Allergan Aesthetics is celebrating a milestone moment for Botox Cosmetic -April 15, 2022, will mark 20 years since the U.S. Food and Drug Administration (FDA) first approved the product to improve the look of moderate to severe glabellar lines.
Botox Cosmetic is the first neurotoxin that is FDA-approved for adults to temporarily improve the look of moderate to severe lines in three areas; frown lines, crow’s feet, and forehead lines.
“It has been remarkable to see how Botox Cosmetic has evolved in 20 years, one scientific study at a time that showcases the clinical significance of this treatment,” said Jean Carruthers, MD, FRCSC, FRC. “Botox Cosmetic has not only changed the trajectory of my career, but also the way the medical aesthetics community practices and teaches.”
Allergan will celebrate with an art installation that will be on a cross-country tour.
Visitors can immerse themselves in a visual, interactive experience that takes them on a celebratory journey of self-affirmation.
The installation will be unveiled in New York City on April 22 at 9 am ET and will be open to the public until April 23 before traveling to Chicago from May 6 to May 8. Finally, the installation will make its way to Los Angeles from May 20 to May 22.
Starting on May 30, a version of the installation will be featured at Resorts World in Las Vegas for eight weeks. Visitors to the art installation will be eligible to receive an exclusive Botox Cosmetic offer powered by Allē, Allergan Aesthetics’ loyalty platform, while supplies last.
“This celebration is about reflecting on the people who helped make Botox Cosmetic a household name,” said Carrie Strom, senior vice president, AbbVie, and president of Global Allergan Aesthetics. “We celebrate our customers, our colleagues, and all the patients who have been a part of our success. We remain dedicated to Botox Cosmetic, the first product of its kind on the market. We are passionate about continuing to drive this market forward, and our experienced team is working closely with healthcare providers to ensure we are delivering meaningful innovations that the market needs with our commitment to ongoing research.”
Photo courtesy of Allergan Aesthetics
